complement protein C5a-based vaccine (AFFiRiS)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecomplement protein C5a-based vaccine (AFFiRiS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor modulators
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffiris Ag
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A